Publications
- Is a chance for slowing down progression CKD in Alport syndrom?Commentary on:KI 81,2012,494-5012012 | First Faculty of Medicine
- An orally active chemokine receptor CCR2 antagonists prevents glomerulosclerosis and renal failure in type 2diabetes. Commentary on:KI 80,2011,68-782011 | First Faculty of Medicine
- Long-Term outcomes of patients with light chain amyloidosis AL afterrenal transplantation with or without stem cell transplantation.Commentary on:NDT 26,2011,2032-20362011 | First Faculty of Medicine
- Association of hemoglobin and survival in peritoneal dialysis patients. Commentary on: ClinJASN 6,2011,1973-19812011 | First Faculty of Medicine
- Presentation and survival of patients with severe acute kidney injury and multiple myeloma-a 20-year experience from a single centre.Commentary on:NDT 25,2010,2,415-4262010 | First Faculty of Medicine
- A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population +12008 | First Faculty of Medicine
- Clinical features, outcomes, and response to corticosteroid treatment of acute tubulointerstitial nephritis: a single centre retrospective cohort study in Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine
- Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis2023 | First Faculty of Medicine
- Terapeutické možnosti blokády komplementu v léčbě atypického hemolyticko-uremického syndromu2023 | First Faculty of Medicine
- Biologická léčba u nemocných s AL amyloidózou2023 | First Faculty of Medicine
Loading network view...